7:18 PM
 | 
Nov 19, 2013
 |  BC Extra  |  Top Story

FDA approves first next-gen sequencer

FDA approved the MiSeqDx genome sequencing system from Illumina Inc. (NASDAQ:ILMN) -- the first high-throughput, next-generation genomic sequencer to be approved by the agency. The whole genome benchtop sequencer, which has been available for research-use only, is now approved in the U.S. for broad clinical use. In an cytochrome P450 family...

Read the full 242 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >